PUBLISHER: Allied Market Research | PRODUCT CODE: 1446401
PUBLISHER: Allied Market Research | PRODUCT CODE: 1446401
The increase in incidence of gynecological disorders is a pivotal driver contributing to the growth of the gynecological devices market. As the prevalence of conditions such as cervical cancer, endometriosis, and uterine fibroids rises, there is a heightened demand for advanced diagnostic and therapeutic solutions. For instance, according to the World Cancer Research Fund International report, 2020, endometrial cancer was the sixth most commonly occurring cancer in women and the 15th most common cancer overall. There were more than 417,000 new cases of endometrial cancer in 2020. Thus, the rise in gynecological disease incidences drives the demand for gynecological devices, thereby fostering market growth.
Furthermore, the growing focus on technological advancements plays a crucial role in shaping the market landscape. Ongoing innovations in medical technology, including minimally invasive surgical techniques, robotic-assisted surgeries, and advanced imaging systems, enhance the precision and efficacy of gynecological procedures. These technological advancements not only improve patient outcomes but also contribute to reduced recovery times and enhanced overall healthcare experiences. In addition, innovative devices that result from technological progress often provide healthcare professionals with better diagnostic capabilities, enabling early detection and intervention. The synergistic impact of increased disease incidence and the integration of cutting-edge technologies positions the gynecological devices market for continued expansion as healthcare systems strive to meet the evolving demands of women's health.
The gynecological devices market is segmented on the basis of product type, end user, and region. On the basis of product type, the market is segmented into gynecological endoscopy devices, endometrial ablation devices, fluid management systems, female sterilization and contraceptive devices, and diagnostic imaging systems. The gynecological endoscopy devices segment is further segmented into laparoscopes, and others. The endometrial ablation devices segment is further segmented into Hydrothermal endometrial ablation devices radiofrequency endometrial ablation devices, balloon endometrial ablation devices, and others. The female sterilization and contraceptive devices segment is further segmented into permanent birth control devices, and temporary birth control devices. The diagnostic imaging systems is further segmented into Ultrasound and Mammography. On the basis of end user, the market is segmented into hospitals, diagnostic centers, and others. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LA (Brazil, Colombia, Argentina, and rest of LA) and MEA (GCC, South Africa, North Africa and rest of MEA).
The major key players that operate in the global gynecological devices market are Stryker Corporation, Richard Wolf GmbH, MedGyn Product Inc., Medtronic Plc, Boston Scientific Corporation, Karl Storz GmbH and Co. KG, Cooper Surgical, Inc., Olympus Corporation, Hologic, Inc., and Ethicon, Inc. The key players have adopted product launch and product approval as the key strategy to expand their product portfolio.
Additional benefits you will get with this purchase are:
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)